1255 Stock Chart & Stats
HK$2.42
-HK$0.22(-9.09%)
At close: 4:00 PM EDT
HK$2.42
-HK$0.22(-9.09%)
Day’s Range― - ―
52-Week RangeHK$0.30 - HK$3.79
Previous CloseN/A
Volume184.00K
Average Volume (3M)0.00
Market Cap
HK$509.97M
Enterprise ValueHK$323.64
Total Cash (Recent Filing)HK$17.92M
Total Debt (Recent Filing)HK$25.87M
Price to Earnings (P/E)38.2
Beta0.10
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding242,845,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.20
Price to Book (P/B)-5.80
Price to Sales (P/S)3.16
P/FCF Ratio-14.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TATA Health International Holdings Ltd. News
1255 FAQ
What was TATA Health International Holdings Ltd.’s price range in the past 12 months?
TATA Health International Holdings Ltd. lowest stock price was HK$0.30 and its highest was HK$3.79 in the past 12 months.
What is TATA Health International Holdings Ltd.’s market cap?
TATA Health International Holdings Ltd.’s market cap is HK$509.97M.
When is TATA Health International Holdings Ltd.’s upcoming earnings report date?
TATA Health International Holdings Ltd.’s upcoming earnings report date is Sep 02, 2026 which is in 25 days.
How were TATA Health International Holdings Ltd.’s earnings last quarter?
TATA Health International Holdings Ltd. released its earnings results on Mar 31, 2026. The company reported -HK$0.03 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is TATA Health International Holdings Ltd. overvalued?
According to Wall Street analysts TATA Health International Holdings Ltd.’s price is currently Overvalued.
Does TATA Health International Holdings Ltd. pay dividends?
TATA Health International Holdings Ltd. pays a Notavailable dividend of HK$0.023 which represents an annual dividend yield of N/A. See more information on TATA Health International Holdings Ltd. dividends here
What is TATA Health International Holdings Ltd.’s EPS estimate?
TATA Health International Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TATA Health International Holdings Ltd. have?
TATA Health International Holdings Ltd. has 242,845,000 shares outstanding.
What happened to TATA Health International Holdings Ltd.’s price movement after its last earnings report?
TATA Health International Holdings Ltd. reported an EPS of -HK$0.03 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of TATA Health International Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:1255
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
TATA Health International Holdings Ltd. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-32.60%
Trailing 12-Months
Company Description
TATA Health International Holdings Ltd.
TATA Health International Holdings Limited functions as an investment holding company with diverse business interests, including the sale of footwear and healthcare goods, in addition to offering financial and online medical services. Its operations are structured into distinct segments: Footwear Products Trading, Healthcare Products Trading, Financial Services, and Online Medical Services. The company engages in both wholesale and retail distribution of footwear, featuring prominent brands like Clarks and Josef Seibel. By December 31, 2021, its retail footprint included 29 stores in Hong Kong and one in Macau. Furthermore, its financial services division provides expertise in securities advisory, investment management, and corporate finance consultancy. The company maintains a geographical presence across Hong Kong, Australia, Macau, and Mainland China. Founded in 1974 and headquartered in Kwai Chung, Hong Kong, the firm rebranded from S. Culture International Holdings Limited to its current name in November 2020.
Technical Analysis
Daphne International Holdings
―
Stella International Holdings Limited
―
361 Degrees International
―
Yue Yuen Industrial (Holdings)
―
C.banner International Holdings Ltd.
―





